Skip to content

Clinical trials

Hemoglobinopathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinopathies Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20041
20053
20061
20071
20083
20094
20102
20111
20121
20133
20143
20156
20161
20178
20182
20193
20206
20217
202210
20234
20244
20257
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Recruiting23
Terminated12
Active, not recruiting10
Unknown status5
Not yet recruiting3
Enrolling by invitation2
Withdrawn1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated6
National Heart, Lung, and Blood Institute (NHLBI)5
University of California, San Francisco5
Baylor College of Medicine4
National Institute of Allergy and Infectious Diseases (NIAID)4
Bellicum Pharmaceuticals3
Editas Medicine, Inc.3
Hospital Universitari Vall d'Hebron Research Institute3
Bangladesh Bioscience Research Group2
Children's Hospital of Philadelphia2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinopathies98
Anemia, Sickle Cell54
Thalassemia36
Hematologic Diseases24
Anemia19
beta-Thalassemia18
Genetic Diseases, Inborn14
Bone Marrow Failure Disorders13
Immunologic Deficiency Syndromes11
Anemia, Hemolytic9

Trials

Showing 51 to 75 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.